ADAMTS9 and breast lobular carcinoma: The expression of AC078883.1 and ADAMTS9-AS1 were significantly decreased, while the expression of the AL035661.1, CBR3-AS1, FTX, and TMEM105 were significantly increased in the patient with breast infiltrating duct and lobular carcinoma with high-risk value (Figure 2B).